HIV drug can prevent complications after stem-cell transplant
An HIV drug helped lower the risk of graft-versus-host disease in persons with blood cancer who had stem-cell transplants to rebuild bone marrow.
Diagnosis & Disease Information
GVHD in pediatric HSCT patients: Clinical trials for Rituximab
The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.
Older blood cancer patients may benefit from cell transplant regimen
A regimen using minimal-intensity radiation therapy before bone marrow or stem cell transplantation may work for older patients who cannot tolerate stronger pretransplant treatment.
Innovative Strategy Improves Immune Recovery of Mismatched Transplants
Scientists have improved a method for bone marrow transplantation from mismatched donors that would help restore the immune system quicker, according to findings presented at the American Society of Hematology Annual Meeting and Exposition in New Orleans in December.
- Loading...
Loading...
Loading... 
Loading...